February 14th 2025
Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
10 Key Steps to Ensure a Smooth Affiliation Among Providers, Health Systems, Hospitals
April 21st 2021How well, and how in-depth, all parties execute each step can determine how long it will take to reach a finalized agreement, what the relationship will be like after the transaction, and whether the parties will be in legal compliance, speakers noted.
Read More
Half of US adults have been administered 1 COVID-19 vaccine dose; researchers identify cause of clotting events associated with AstraZeneca vaccine; Anthony Fauci, MD, the chief medical advisor to the president, says he believes a decision on whether to resume the J&J vaccine will come by Friday.
Read More
Dr Misha Rosenbach on the Relationship Between Climate Change and Medicine
April 17th 2021A changing climate affects every organ system of the body, individual patients, and population-based health, noted Misha Rosenbach, MD, associate professor of dermatology and internal medicine at the University of Pennsylvania.
Watch
Avalere Report Looks at Geographic Challenges to Accessing CAR T-Cell Therapies
April 17th 2021Given that some patients may need to travel out of state to access CAR T sites of care, some may not have a clear understanding of their insurance benefits, including requirements for out-of-state or out-of-network treatment, as well as adequate assistance with the costs of medical-related travel.
Read More
What’s Next in Health Policy After the First 100 Days of the Biden Presidency?
April 16th 2021With President Joe Biden marking his 100th day in office at the end of the month, a health policy strategist sat down for a conversation to discuss the new administration’s achievements and challenges.
Read More
Low-Income, Non-White Patients Delay Care Using HDHPs, Study Says
April 15th 2021A poster at the Academy of Managed Care Pharmacy 2021 meeting examined the impact of high-deductible health plans (HDHPs) on access to health care and resource use in the United States and the interaction of race, ethnicity, and income.
Read More
PAH Treatment Patterns and Costs Related to Hospitalization
April 15th 2021New research presented at AMCP 2021, the annual meeting of the Academy of Managed Care Pharmacy, evaluated treatment patterns and costs related to hospitalization for patients with pulmonary arterial hypertension (PAH).
Read More
How Can Medicare Part D Keep Up With a More Complex, Costly Landscape?
April 14th 2021Compared with when Medicare Part D launched, therapies today are more expensive. A panel at the Academy of Managed Care Pharmacy 2021 meeting discussed how the benefit needs to adapt to keep up with the future.
Read More
Dr Perry N. Halkitis Discusses COVID-19 Vaccine Hesitancy Among Persons Living With HIV
April 14th 2021For some living with HIV, old wounds have reopened during the COVID-19 pandemic, explained Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health and director of the Center for Health, Identity, Behavior and Prevention Studies.
Watch
Adverse reactions to the Johnson & Johnson vaccine cause some states to pause distribution; the Biden administration proposes creation of a $6.5 billion medical research agency aiming to cure cancer and other diseases; Pfizer/BioNTech seeks expansion of its COVID-19 vaccine emergency use authorization in adolescents.
Read More
Examination of Marshallese Living in US Illustrates Health Disparities in T2D
April 10th 2021A high proportion of Marshallese, or Marshall Islanders, living on the mainland Unites States, have undiagnosed hypertension and type 2 diabetes (T2D), according to findings that will be used to address disparities in Native Hawaiian and Pacific Islander populations.
Read More
Pricing, Payment Reform, and Politics Are Inextricably Linked in Cancer Care
April 9th 2021On day 2 of this year’s Community Oncology Conference, a panel of government and health policy experts gathered to discuss the hot-button issue of political influence on cancer policy and the damage community oncology has suffered this past year.
Read More
Patients Are the “Value” Focus in Cancer Care, Panelists Agree
April 9th 2021There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.
Read More
Survey Finds Provider Burnout, Disengagement as Most Potentially Disruptive Trends in Health Care
April 9th 2021A 2021 survey on health care trends to monitor finds provider burnout, disengagement, and shortage of health care professionals as the most potentially disruptive issues facing hospitals and health systems in the next 3 years.
Read More
Dr Lalan Wilfong Discusses Growth in Remote Monitoring, Future of Value-Based Cancer Care
April 9th 2021Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.
Watch
Dr Edward Licitra on Aligning Patient, Physician Goals in Value-Based Cancer Care
April 9th 2021Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.
Watch
Palliative Care Encompasses Much More Than End-of-Life Care
April 8th 2021A popular misconception of palliative care is that it only has importance toward making patients comfortable at the end of their lives, noted a palliative care physician on the first day of the 2021 Community Oncology Conference, presented by the Community Oncology Alliance.
Read More